{
  "id": "5fd779b4a43ad31278000004",
  "type": "factoid",
  "question": "Which particular intersex phenotype is related to steroid reductase?",
  "ideal_answer": "Steroid reductase mutations are associated with both sex-determining and non-syndromic hypospadias",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
    "http://www.ncbi.nlm.nih.gov/pubmed/31981690",
    "http://www.ncbi.nlm.nih.gov/pubmed/9247984",
    "http://www.ncbi.nlm.nih.gov/pubmed/24383016",
    "http://www.ncbi.nlm.nih.gov/pubmed/11392378",
    "http://www.ncbi.nlm.nih.gov/pubmed/25077171",
    "http://www.ncbi.nlm.nih.gov/pubmed/21714467",
    "http://www.ncbi.nlm.nih.gov/pubmed/8723114",
    "http://www.ncbi.nlm.nih.gov/pubmed/8262007"
  ],
  "snippets": [
    {
      "text": "Gender identity and role in a pedigree of Arabs with intersex due to 5 alpha reductase-2 deficiency",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9247984",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Between 1986 and 1995, a pedigree of six Arabs with male pseudohermaphroditism due to 5 alpha reductase-2 deficiency have been identified.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9247984",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the 20 yr since it was established that impairment of dihydrotestosterone formation is the cause of a rare form of human intersex, a wealth of information has accumulated about the genetics, endocrinology, and variable phenotypic manifestations, culminating in the cloning of cDNAs encoding two 5 alpha-reductase genes and documentation that mutations in the steroid 5 alpha-reductase 2 gene are the cause of 5 alpha-reductase deficiency.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8262007",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It is also imperative to establish whether defects in steroid 5 alpha-reductase 2, perhaps in the heterozygous state, are responsible for a portion of cases of sporadic hypospadias, to determine whether 5 alpha-reductase plays a role in progesterone action in women, and to elucidate the relation between androgen action and gender role behavior.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8262007",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Virilization of the external genitalia in the male fetus requires testosterone and dihydrotestosterone (DHT), which is formed from testosterone by the action of the enzyme, 5alpha-reductase type 2 (5alphaR-2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11392378",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Steroid 5-alpha-reductase 2 deficiency is an autosomal recessive disorder with clinical spectrum ranges from a male phenotype with hypospadia to a female phenotype with normal wolffian structures",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21714467",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Steroid 5-alpha-reductase 2 deficiency is a rare disorder leading to male pseudohermaphroditism, a condition characterized by incomplete differentiation of male genitalia in 46,XY patients. H",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24383016",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ch impairs DHT formation (mutation within the 5alphaR-2 gene or 5alphaR-2 inhibitors) or normal function of the AR (mutation in the AR gene, antiandrogens) may result in insufficient androgen action in the male fetus and in subsequent undervirilization in the newborn. Hypospadias may ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11392378",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "oding sequences of the SRY gene (case 1) and 2 candidates for monogenic hypospadias, namely MAMLD1 (mastermind-like domain containing 1) and SRD5A2 (steroid-5-alpha-reductase, alpha polypeptide 2). Sequencing of the entire SRY gene, incl",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 1974, a lack of 5\u03b1-dihydrotestosterone (5\u03b1-DHT), the most potent androgen across species except for fish, was shown to be the origin of a type of pseudohermaphrodism in which boys have female-like external genitalia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31981690",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Molecular studies were focused on coding sequences of the SRY gene (case 1) and 2 candidates for monogenic hypospadias, namely MAMLD1 (mastermind-like domain containing 1) and SRD5A2 (steroid-5-alpha-reductase, alpha polypeptide 2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "None of the identified polymorphisms cosegregated with the intersexual phenotype, thus, we cannot confirm that hypospadias may be associated with polymorphism in the coding sequence of the studied genes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This animal was classified as a compound sex reversal (78,XX, SRY-negative) with the hypospadias syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hypospadias in a male (78,XY; SRY-positive) dog and sex reversal female (78,XX; SRY-negative) dogs: clinical, histological and genetic studies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21893969",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Hence, steroid 5 alpha-reductase deficiency should be considered not only in sex reversed patients with female or ambiguous phenotypes, but also in those with mild symptoms of undermasculinization as encountered in patients with hypospadias and/or micropenis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8723114",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8723114",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A classification based on the severity of the masculinization defect may be used for correlation of phenotypes with enzyme activities and genotypes, and for comparisons of phenotypes between different patients as the basis for clinical decisions to be made in patients with pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8723114",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inactivating mutations of the 5\u03b1-steroid reductase type-2 (SRD5A2) gene result in a broad spectrum of masculinization defects, ranging from a male phenotype with hypospadias to a female phenotype with Wolffian structures.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25077171",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "male pseudohermaphroditism"
}